These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 16958820

  • 1. A retrospective study to determine the impact of medical- and lifestyle-based contraindications to a prescribed HAART regimen on clinical outcomes and adherence.
    Lal LS, Grimes RM, Swint JM, Risser J.
    J Clin Pharm Ther; 2006 Oct; 31(5):429-39. PubMed ID: 16958820
    [Abstract] [Full Text] [Related]

  • 2. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML, Jackson GL, Smith R, Wilson KH.
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS.
    Garvie PA, Lensing S, Rai SN.
    Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
    Dai Y, Qiu ZF, Li TS, Han Y, Zuo LY, Xie J, Ma XJ, Liu ZY, Wang AX.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1677-82. PubMed ID: 17097013
    [Abstract] [Full Text] [Related]

  • 5. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.
    AIDS; 2008 Nov 12; 22(17):2371-80. PubMed ID: 18981777
    [Abstract] [Full Text] [Related]

  • 6. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE, Hogan JW, Mitty JA, Bazerman LB, Delong AK, Loewenthal H, Caliendo AM, Flanigan TP.
    AIDS; 2007 Jul 11; 21(11):1473-7. PubMed ID: 17589194
    [Abstract] [Full Text] [Related]

  • 7. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD, Keruly JC.
    Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456
    [Abstract] [Full Text] [Related]

  • 8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2009 Apr 01; 27(4):222-35. PubMed ID: 19246124
    [Abstract] [Full Text] [Related]

  • 9. Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.
    Seyler C, Adjé-Touré C, Messou E, Dakoury-Dogbo N, Rouet F, Gabillard D, Nolan M, Toure S, Anglaret X.
    AIDS; 2007 May 31; 21(9):1157-64. PubMed ID: 17502726
    [Abstract] [Full Text] [Related]

  • 10. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
    Castor D, Vlahov D, Hoover DR, Berkman A, Wu YF, Zeller B, Brechtl J, Hammer SM.
    J Med Virol; 2009 Aug 31; 81(8):1323-35. PubMed ID: 19551816
    [Abstract] [Full Text] [Related]

  • 11. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ.
    Clin Infect Dis; 2008 Jan 15; 46(2):305-12. PubMed ID: 18171267
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 15; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 13. [Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status].
    Rodríguez de Schiavi MS, Scrigni A, García Arrigoni P, Bologna R, Barboni G, Redondo J, Nastri M, Mecikovsky D, Cantisano C, Moreno R, Siciliani D, Lencina M, Luedicke N, Rezzónico G, Torolla JL, López Papucci S, Luis M, Libonati C, Gamba L, Barbarysky J, Pérez Hernández E, Zlatkes R.
    Arch Argent Pediatr; 2009 Jun 15; 107(3):212-20. PubMed ID: 19543629
    [Abstract] [Full Text] [Related]

  • 14. Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique.
    San Lio MM, Carbini R, Germano P, Guidotti G, Mancinelli S, Magid NA, Narciso P, Palombi L, Renzi E, Zimba I, Marazzi MC.
    Clin Infect Dis; 2008 May 15; 46(10):1609-16. PubMed ID: 18419498
    [Abstract] [Full Text] [Related]

  • 15. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
    Glikman D, Walsh L, Valkenburg J, Mangat PD, Marcinak JF.
    Pediatrics; 2007 May 15; 119(5):e1142-8. PubMed ID: 17452493
    [Abstract] [Full Text] [Related]

  • 16. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG.
    HIV Med; 2007 Jan 15; 8(1):46-54. PubMed ID: 17305932
    [Abstract] [Full Text] [Related]

  • 17. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
    Llibre JM, Domingo P, del Pozo MA, Miralles C, Galindo MJ, Viciana I, Moreno S, Schapiro JM, Clotet B.
    J Antimicrob Chemother; 2008 Jan 15; 61(1):206-9. PubMed ID: 17999972
    [Abstract] [Full Text] [Related]

  • 18. A programme of symptom management for improving quality of life and drug adherence in AIDS/HIV patients.
    Chiou PY, Kuo BI, Lee MB, Chen YM, Chuang P, Lin LC.
    J Adv Nurs; 2006 Jul 15; 55(2):169-79. PubMed ID: 16866809
    [Abstract] [Full Text] [Related]

  • 19. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, Mntambo M, Thomas M, Nixon K, Holst HL, Karim QA, Rollins NC, Coovadia HM, Giddy J.
    BMC Pediatr; 2007 Mar 17; 7():13. PubMed ID: 17367540
    [Abstract] [Full Text] [Related]

  • 20. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T, Galatowicz G, Bunce C, Calder V, Lynn WA, Lightman S.
    Clin Immunol; 2006 Nov 17; 121(2):191-7. PubMed ID: 16987710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.